Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Vacuolar-type H+-ATPase (V-ATPase) Vo c-subunit is a fundamental component of the V-ATPase enzyme complex, a multi-subunit molecular motor that functions as an ATP-dependent proton pump (GeneCards, https://www.genecards.org/cgi-bin/cardprep.pl?gene=ATP6V0C). Encoded by the ATP6V0C gene, this 16 kDa proteolipid forms a rotating ring within the membrane-embedded V0 domain, which is responsible for translocating protons across biological membranes to acidify intracellular organelles like lysosomes and endosomes (NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC2852119/). This acidification is crucial for diverse cellular processes, including protein degradation, receptor-mediated endocytosis, and nutrient sensing via the mTOR pathway (NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC7674343/). In disease states, the c-subunit is often overexpressed in cancer cells to promote an acidic microenvironment conducive to invasion and metastasis, and it plays a key role in bone resorption by osteoclasts in osteoporosis (NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC5726535/). Mutations in ATP6V0C have been linked to neurodevelopmental disorders, including epilepsy and intellectual disability, highlighting its importance in neuronal function (MDPI, https://www.mdpi.com/2073-4409/12/11/1519; Brain, https://academic.oup.com/brain/article/146/4/1431/6692484). While potent inhibitors like bafilomycin A1 and concanamycin A target the c-subunit to block proton transport, their high systemic toxicity has challenged the development of clinically viable therapeutics, leading to ongoing research into more selective V-ATPase modulators (ResearchGate, https://www.researchgate.net/publication/343014433_Cryo-EM_structure_of_bafilomycin_A1_bound_intact_bovine_V-ATPase).
Inhibition of the V-ATPase proton pump by binding to the c-subunit ring in the V0 domain, thereby blocking the rotation required for proton translocation and preventing the acidification of intracellular and extracellular compartments (NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC2852119/; ResearchGate, https://www.researchgate.net/publication/343014433_Cryo-EM_structure_of_bafilomycin_A1_bound_intact_bovine_V-ATPase).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATPase H+ transporting V0 subunit c (ATP6V0C).